The FDA is investigating a broader set of medications that may be repackaged valsartan after recalling the popular blood pressure drug over its discovery that it contains a carcinogen, the agency said today.
from Ushome | Mail Online https://ift.tt/2C4XRPS
via IFTTT https://ift.tt/eA8V8J
from Ushome | Mail Online https://ift.tt/2C4XRPS
via IFTTT https://ift.tt/eA8V8J
FDA warns blood pressure drugs investigation for cancer-causing chemical
![FDA warns blood pressure drugs investigation for cancer-causing chemical]()
Reviewed by Unknown
on
September 01, 2018
Rating:
No comments: